Deau B - Search Results

1

Peripheral blood 8 colour flow cytometry monitoring of hairy cell leukaemia allows detection of high-risk patients.

Garnache Ottou F, Chandesris MO, Lhermitte L, Callens C, Beldjord K, Garrido M, Bedin AS, Brouzes C, Villemant S, Rubio MT, Belanger C, Suarez F, Deau B, Lefrère F, Hermine O, Asnafi V, Varet B, Macintyre E. Garnache Ottou F, et al. Among authors: deau b. Br J Haematol. 2014 Jul;166(1):50-9. doi: 10.1111/bjh.12839. Epub 2014 Mar 25. Br J Haematol. 2014. PMID: 24661013 Free article.

2

Macrophage, mast cell and T lymphocyte infiltrations are independent predictive biomarkers of primary refractoriness or early relapse in classical Hodgkin lymphoma.

Deau B, Bachy E, Ribrag V, Delarue R, Rubio MT, Bosq J, Varet B, Brousse N, Hermine O, Canioni D. Deau B, et al. Leuk Lymphoma. 2013 Jan;54(1):41-5. doi: 10.3109/10428194.2012.698274. Epub 2012 Jul 9. Leuk Lymphoma. 2013. PMID: 22667341

3

Impact of genotype in relapsed and refractory acute myeloid leukaemia patients treated with clofarabine and cytarabine: a retrospective study.

Mondesir J, Alary AS, Sibon D, Willems L, Deau B, Suarez F, Hermine O, Fontenay M, Bouscary D, Kosmider O, Tamburini J. Mondesir J, et al. Among authors: deau b. Br J Haematol. 2019 Oct;187(1):65-72. doi: 10.1111/bjh.16045. Epub 2019 Jun 18. Br J Haematol. 2019. PMID: 31215036 Free article.

4

Pegylated liposomal doxorubicin: an efficient treatment in patients with Hodgkin lymphoma relapsing after high dose therapy and stem cell transplation.

Clozel T, Deau B, Benet C, Franchi P, Robin M, Madelaine I, Thieblemont C, de Kerviler E, Brière J, Brice P. Clozel T, et al. Among authors: deau b. Br J Haematol. 2013 Sep;162(6):846-8. doi: 10.1111/bjh.12428. Epub 2013 Jun 24. Br J Haematol. 2013. PMID: 23789905 Free article. No abstract available.

5

PET2 -driven de-escalation therapy in 64 high-risk Hodgkin Lymphoma patients treated with escalated BEACOPP.

Deau B, Franchi P, Briere J, Ohnona J, Tamburini J, Thieblemont C, Brice P. Deau B, et al. Br J Haematol. 2015 Jul;170(2):278-81. doi: 10.1111/bjh.13287. Epub 2015 Jan 9. Br J Haematol. 2015. PMID: 25580881 Free article. No abstract available.

6

Tandem haematopoietic stem cell transplantation for High Risk relapsed/refractory Hodgkin Lymphoma: a LYSA study.

Deau B, Amorim S, Perrot A, Quittet P, Cornillon J, Chaoui D, Marolleau JP, Oberic L, Le Du K, Fornecker LM, Tournilhac O, Veillard AS, Chaillol I, Robin M, Tamburini J, Brice P. Deau B, et al. Br J Haematol. 2018 May;181(3):341-349. doi: 10.1111/bjh.15184. Epub 2018 Apr 2. Br J Haematol. 2018. PMID: 29611187 Free article. Clinical Trial.

7

The role of radiotherapy as salvage and/or consolidation treatment in relapsed/refractory and high-risk diffuse large B-cell lymphoma.

Grignano E, Laurent J, Deau B, Burroni B, Bouscary D, Kirova YM. Grignano E, et al. Among authors: deau b. Eur J Haematol. 2018 Apr 16. doi: 10.1111/ejh.13080. Online ahead of print. Eur J Haematol. 2018. PMID: 29660176

8

Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5-year analysis of the French early access program (EPA).

Manson G, Herbaux C, Schiano JM, Casasnovas O, Stamatoullas A, Deau B, Schmitt A, Regny C, Bouabdallah K, Chauchet A, Ghesquieres H, Tempescul A, Dulery R, Nicolas-Virelizier E, Delmer A, Borel C, Dercle L, Brice P, Houot R; Lymphoma Study Association (LYSA). Manson G, et al. Among authors: deau b. Br J Haematol. 2022 Jul;198(1):203-206. doi: 10.1111/bjh.18198. Epub 2022 Apr 21. Br J Haematol. 2022. PMID: 35445392 Free article. No abstract available.

9

Tandem versus single haematopoietic stem cell transplant and BV maintenance in relapsed/refractory Hodgkin lymphoma: A matched cohort analysis from the LYSA.

Marouf A, Molinari N, Sibon D, Cottereau AS, Kanoun S, Antoine C, Debureaux PE, Cavalieri D, Fornecker LM, Casasnovas RO, Herbaux C, Amorim S, Rossi C, Bouscary D, Brice P, Ghesquieres H, Tamburini J, Deau B. Marouf A, et al. Among authors: deau b. Br J Haematol. 2023 Jul;202(2):379-383. doi: 10.1111/bjh.18859. Epub 2023 May 16. Br J Haematol. 2023. PMID: 37192755

10

Acute monocytic leukemia with coexpression of minor BCR-ABL1 and PICALM-MLLT10 fusion genes along with overexpression of HOXA9.

Sindt A, Deau B, Brahim W, Staal A, Visanica S, Villarese P, Rault JP, Macintyre E, Delabesse E. Sindt A, et al. Among authors: deau b. Genes Chromosomes Cancer. 2006 Jun;45(6):575-82. doi: 10.1002/gcc.20320. Genes Chromosomes Cancer. 2006. PMID: 16518848

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters